BDNF and attention deficit-hyperactivity disorder: However, the cortisol inhibition effects of oroxylin A have not been reported to date, but the potential neurological effects (i.e., dopamine reuptake inhibition, regulation of brain-derived neurotrophic factor (BDNF) expression, improved memory and cognitive functions, neuroprotective actions via decreasing markers for neuroinflammation, improvement of the attention-deficit hyperactivity disorder (ADHD)-like behaviors) do indicate its activity within the nervous system [40].